ASDZF yields 20000.00% · JNJ yields 2.13%● Live data
📍 ASDZF pulled ahead of the other in Year 1
Combined, ASDZF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of ASDZF + JNJ for your $10,000?
Arctic Star Exploration Corp., a junior natural resource company, acquires, explores for, and develops mineral properties in Canada and Finland. The company primarily explores for diamond and niobium/rare earth deposits. Its flagship project is the Diagras property that consists of 58 contiguous claims with an area of 48,346 hectares located in the north-eastern part of the prolific Lac de Gras kimberlite field. The company also owns 1000% interest in the Timantti diamond project consisting of two exploration permits, which includes the 243 hectares exploration Solavaara Permit and the 882 hectares Vaimouso permit; and 193,700 hectares exploration reservation located in Finland. In addition, it owns 100% interest in the Stein property that consists of four 4 contiguous prospecting permits covering an area of 105,637 hectares located 85 km north-west of Taloyoak. The company was formerly known as Arctic Star Diamond Corp. and changed its name to Arctic Star Exploration Corp. in July 2011. Arctic Star Exploration Corp. was incorporated in 2001 and is headquartered in Vancouver, Canada.
Full ASDZF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.